Provided by Tiger Fintech (Singapore) Pte. Ltd.

Plus Therapeutics, Inc.

0.4701
-0.0577-10.93%
Volume:6.48M
Turnover:3.09M
Market Cap:28.44M
PE:-0.20
High:0.5100
Open:0.5100
Low:0.4550
Close:0.5278
Loading ...

Plus Therapeutics Announces $1.6 Million Advance Payment From Cprit

THOMSON REUTERS
·
23 Jul

Plus Therapeutics Inc. Announces Date for 2025 Annual Stockholders Meeting

Reuters
·
22 Jul

Plus Therapeutics Inc. Replaces Auditor BDO Amid Internal Control Concerns

Reuters
·
19 Jul

Plus Therapeutics Presents Respect-Lm Clinical Trial Results for Reyobiq™ in Patients With Leptomeningeal Metastases

THOMSON REUTERS
·
15 Jul

Plus Therapeutics Inc - Company to Request End of Phase 1 Meeting With FDA

THOMSON REUTERS
·
08 Jul

Plus Therapeutics Announces Initial Patients Successfully Treated in Respect-Lm Dose Optimization Trial for Reyobiq™ in Leptomeningeal Metastases

THOMSON REUTERS
·
08 Jul

BRIEF-Plus Therapeutics Announces FDA Agreement To Initiate ReSPECT-LM Dose Optimization Trial For REYOBIQ In Leptomeningeal Metastases

Reuters
·
30 Jun

Plus Therapeutics Inc - Trial to Evaluate Safety, Pharmacokinetics, and Efficacy Endpoints

THOMSON REUTERS
·
30 Jun

Plus Therapeutics Inc - Trial to Enroll up to 24 Patients at 44.1 Mci Dose

THOMSON REUTERS
·
30 Jun

Plus Therapeutics Announces FDA Agreement to Initiate Respect-Lm Dose Optimization Trial for Reyobiq™ in Leptomeningeal Metastases

THOMSON REUTERS
·
30 Jun

Plus Therapeutics provides business update on CNSide Diagnostics subsidiary

TIPRANKS
·
26 Jun

Plus Therapeutics Provides Business Update on Cnside Diagnostics Subsidiary

THOMSON REUTERS
·
26 Jun

Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 a.m. Et

THOMSON REUTERS
·
26 Jun

BUZZ-Plus Therapeutics jumps after FDA allows co to begin human trials for cancer therapy

Reuters
·
25 Jun

Why Is Plus Therapeutics Stock (PSTV) Up 100% Today?

TIPRANKS
·
25 Jun

Plus Therapeutics Says FDA Clears Reyobiq IND Application for Pediatric Brain Cancer; Shares Up Pre-Bell

MT Newswires Live
·
25 Jun

BRIEF-Plus Therapeutics Announces FDA Clearance Of Its Investigational New Drug Application

Reuters
·
25 Jun

Plus Therapeutics Announces FDA Clearance of Its Investigational New Drug Application Using Reyobiqtm for the Treatment of Childhood Brain Cancer

THOMSON REUTERS
·
25 Jun

Plus Therapeutics announces restructuring of $15M equity financing

TIPRANKS
·
24 Jun

Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing

THOMSON REUTERS
·
24 Jun